HOME PAGE CONTACT US MAILING LIST NEWS MAP INFO

  WORK WITH US
Job Offers

Seeking Worldwide Representations
  ABOUT US
History
  PARTNERS
Group
  EQUIPMENT
Chrispro® Jet-Mill
Isolated Micronizers
Isolators
Feeders
Cryogenic exchangers
Development
  PROCESS EXPLANATION
Micronization Explanation
  CUSTOM SERVICE
Micronizing Service
  REGULATORY
Validation
CQ Services
Agreements & Certificates





micromacinazione SA

The european micronization leader of bulk active ingredients for the pharmaceutical industry

OFFERING
  • Micronization Contract Services in 2 separate fully cGMP buildings utilizing 4 opposed and 21 spiral jet mills systems, most of them highly contained in flexible and rigid isolators down to OEL < 1 µg/m3 and all of them engineered in-house.

  • Own designed micronization systems , both spiral and opposed jet mills, that have been developed since the company inception in 1970 and sold worldwide to more than 300 satisfied customers.

  • In the past 15 years a range of glove-box isolators for a large variety of sterile and high containment applications have been developed for internal use and have been sold to the international pharmaceutical market.

  • A new range of powder vacuum transfer systems coupled with flexible isolators and a drum docking system for OEL < 1 µg/m3 has been developed in the past years, are daily used in-house on a couple of micronization booth and are being sold internationally.

micromacinazione THEREFORE OFFERS A UNIQUE COMBINATION OF ENGINEERING AS WELL AS END USER EXPERTISE.




Visit us at our Stand D30 at the CHEMSPEC - Europe in Barcelona, June 13-14, 2012.
We are looking forward to meeting you.






We are looking forward to meeting you.




micromacinazione SA - Address: Via Cantonale - 6995 Molinazzo di Monteggio (CH)
Phone: +41(0)91 611 36 36 Fax: +41(0)91 611 36 37 - e-mail: info@micromacinazione.com

Copyright ©2006 - micromacinazione SA - Tutti i diritti sono riservati.

Contact for Technical Questions

FDA INSPECTION

We are glad to announce that recently (28-30 March 2012) we passed a 3-day FDA inspection successfully at both our manufacturing sites, Molinazzo di Monteggio and Madonna del Piano, without any observation.


NANOPARTICLES

Possibility to produce nanoparticles by super- critical fluid precipitation under fully cGMP conditions.